Michael J. Pederson
Corporate Officer/Principal bei Abbott Ltd.
Vermögen: 6 Mio $ am 31.05.2024
Profil
Michael J.
Pederson is currently working as a Finance Manager-Licensing & Acquisitions at Abbott Ltd.
Prior to this, he worked as the Chief Executive Officer at Vytronus, Inc. and as an Independent Director at EPIX Therapeutics, Inc.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ABBOTT LABORATORIES
0,00% | 28.02.2023 | 63 231 ( 0,00% ) | 6 Mio $ | 31.05.2024 |
Aktive Positionen von Michael J. Pederson
Unternehmen | Position | Beginn |
---|---|---|
Abbott Ltd. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael J. Pederson
Unternehmen | Position | Ende |
---|---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Vorstandsvorsitzender | 06.04.2015 |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Electronic Technology |
Abbott Ltd. |